Pharma Industry News

J&J’s comeback kid Spravato heads for blockbuster status

After a slow start, the novel esketamine nasal spray for depression is now J&J’s fastest-growing medication.

After a slow start, the novel esketamine nasal spray for depression is now J&J’s fastest-growing medication.

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

Leave a Comment

[mwai_chat window="true" fullscreen="true"]